Anbio Biotechnology (NASDAQ:NNNN) Shares Gap Down – Should You Sell?

Anbio Biotechnology (NASDAQ:NNNN) shares gapped down before the market opened on Wednesday . The stock had previously closed at $8.35, but opened at $7.92. Anbio Biotechnology shares last traded at $8.3740, with a volume of 11,978 shares traded.

Analyst Ratings Changes

Separately, Weiss Ratings lowered shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Wednesday, July 29th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Anbio Biotechnology has a consensus rating of “Sell”.

Anbio Biotechnology Stock Down 5.4%

The firm’s 50 day moving average is $11.55 and its two-hundred day moving average is $20.74.

About Anbio Biotechnology

Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.